Fast-Track Cities Plus initiative

Goals for Fast-Track Cities+ (FTC+) Birmingham

Purpose

The purpose of Fast-Track Cities+ Birmingham is to strengthen:

  • existing programmes and accelerate locally coordinated responses to end blood-borne viruses as major public health threats by 2030, including:
    • HIV/AIDS
    • viral hepatitis (hepatitis B and C)
    • tuberculosis (TB)
  • communities and provide timely testing and treatment services that support those living with these conditions, without prejudice and stigma

Local context

A FTC+ community engagement and needs assessment was carried out to gain an understanding of the local context.

Download community engagement and needs assessment

The community engagement and needs assessment informed the recommendations set out in the FTC+ action plan, a jointly owned document for local stakeholders involved in tackling blood borne viruses (BBVs) and Tuberculosis (TB).

Download FTC+ action plan

Targets

The targets below have been developed and adapted from global and national targets to fit Birmingham’s context and the data which is available on the local level.

They have been informed by local clinicians, epidemiologists and other experts in the field.

HIV (UN AIDS 95-95-95 targets)

  • 95% of people living with HIV (PLHIV) knowing their HIV status
  • 95% of people who know their HIV-positive status on HIV treatment
  • 95% of PLHIV on HIV treatment being virally suppressed
  • Zero stigma and discrimination

Hepatitis B

  • 90% reduction in new cases of chronic hepatitis B infections by 2030 (compared to 2015)
  • 65% reduction in deaths from hepatitis B by 2030 (compared to 2015)
  • 90% childhood hepatitis B vaccination coverage (third dose coverage)
  • 100% hepatitis B virus birth-dose vaccination coverage or other approach to prevent mother-to-child transmission
  • 90% coverage of vaccination in prisoners, sexual health clinic clients, homeless individuals, sex workers, contacts of hepatitis B infected cases, asylum seekers, new migrants and people who inject drugs (PWID)

Hepatitis C

  • 90% reduction in new cases of chronic hepatitis C infections by 2025 (compared to 2015)
  • 65% reduction in deaths from hepatitis C by 2025 (compared to 2015)
  • 100% of injecting drug users reporting adequate needle and syringe provision for their needs
  • 90% of those living with hepatitis C diagnosed
  • 90% of eligible persons with current hepatitis C infection started treatment

Tuberculosis (TB)

  • 90% reduction in TB incidence (compared to 2015)
  • 95% reduction in TB deaths (compared to 2015)
  • Achieve 1358 Latent TB infection tests per year in Birmingham
  • Achieve 90% treatment completion rates (12 month outcome) by 2026
  • 80% BCG vaccination coverage for all children in the Birmingham local authority
  • 100% of eligible TB cases offered a HIV test

Page last updated: 24 October 2023

rating button